Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Application of Recombinant Human Erythropoietin in Premature Infants
NCT03110341Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Apr 2017
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of erythropoietin in encephalopathy, sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Status: unknown.
02
Drugs
erythropoietin
03
Conditions
encephalopathy
Beyond the preview
Go deeper on NCT03110341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110341.